CD Biosynsis offers cutting-edge Vibrio natriegens Base Editing Services to achieve highly precise, single-nucleotide substitutions in this ultra-fast-growing chassis. V. natriegens is a prime host for industrial biomanufacturing due to its exceptional growth rate (approximately 10 min doubling time). Base editing is a revolutionary technology that allows for the direct conversion of specific nucleotide pairs (e.g., C to T or A to G) without creating a double-strand break (DSB) in the DNA, significantly increasing editing efficiency and minimizing unwanted indel byproducts. Our services are essential for optimizing metabolic pathways by introducing beneficial point mutations, modifying ribosome binding sites (RBS), and fine-tuning promoter strengths. We provide comprehensive design, construction, and high-throughput screening to realize rational strain improvement in the complex V. natriegens dual-chromosome genome.
Get a QuoteTraditional gene editing in V. natriegens, which often requires homology-directed repair (HDR) following a DSB, can be inefficient and time-consuming. Base editing overcomes this by employing a Cas9 nickase fused to a base deaminase, enabling irreversible chemical conversion of a base within a precise window, without relying on error-prone repair pathways. This capability is critical for optimizing the expression and activity of key enzymes in engineered pathways, particularly given V. natriegens's rapid metabolic flux. Our platform ensures efficient delivery and stable expression of the base editor systems specific to this dual-chromosome host, accelerating the Design-Build-Test-Learn cycle.
Rational gRNA Design
Computational design of single guide RNAs (gRNAs) to position the target base within the editor's optimal editing window (typically positions 4-8).
Editing Window Validation
Verification that the desired base change (e.g., C to T) and the potential off-target sites fall outside the deamination range to ensure high on-target specificity.
Dual-Chromosome Targeting
Design strategies optimized for the V. natriegens genome structure, ensuring efficient editing of targets located on either Chromosome I or Chromosome II.
Cytosine Base Editors (CBE)
Systems (e.g., BE3, BE4) enabling the efficient conversion of C to T (or G to A on the non-target strand) for engineering nonsense or missense mutations.
Adenine Base Editors (ABE)
Systems enabling the conversion of A to G (or T to C on the non-target strand), critical for introducing specific codon changes or activating gene expression.
Delivery and Expression
Stable delivery of the base editor (dCas9-deaminase fusion) and gRNA via optimized shuttle vectors for V. natriegens, often inducible for transient expression.
Promoter and Terminator Tuning
Using C-to-T or A-to-G edits in regulatory regions to precisely modulate gene expression strength, essential for balancing pathway flux.
Ribosome Binding Site (RBS) Modulation
Single-base changes within the RBS to finely tune translation initiation rates, optimizing protein levels for metabolic intermediates.
Enzyme Optimization
Introducing missense mutations to enhance enzyme stability, substrate specificity, or catalytic turnover (kcat), guided by structural bioinformatics.
A systematic process for design, editing, screening, and validation.
1. Rational Target Design
2. Editor Construction & Delivery
3. High-Throughput Screening
4. Validation & Delivery
Identify optimal single-base substitutions based on metabolic modeling or sequence homology.
Design gRNAs to place the target base within the editor's optimal deamination window.
Bioinformatics check for minimal off-target effects and PAM sequence accessibility.
Construct the Base Editor system (CBE or ABE) and gRNA on a transient expression vector.
Transformation/conjugation of the editing complex into the V. natriegens host strain.
Induce transient expression of the editor to minimize DNA damage and select for edits.
Confirmation of the desired single-base substitution via Sanger sequencing of the locus.
Phenotypic characterization and stability testing of the final engineered strain.
Delivery of the validated V. natriegens strain and comprehensive editing report.
DSB-Free High Efficiency
Avoids the need for a DNA double-strand break (DSB) and homology-directed repair (HDR), resulting in significantly higher editing efficiencies and minimal indel byproducts.
Unmatched Precision
Enables the introduction of specific C-to-T or A-to-G point mutations required for subtle, fine-tuning of gene expression and protein function, critical for pathway balancing.
Dual-Chromosome Expertise
Proven capability to design and execute high-efficiency base editing on genes located on either the primary or secondary chromosome of V. natriegens.
Accelerated Optimization
The high success rate and reduced need for extensive screening drastically accelerate the strain development pipeline compared to traditional CRISPR/HDR methods.
1. What types of base substitutions can your service perform?
We primarily offer Cytosine Base Editors (CBE) for C to T conversions (and the reverse G to A), and Adenine Base Editors (ABE) for A to G conversions (and the reverse T to C). These cover four out of the possible twelve base transitions.
2. How does Base Editing avoid DNA double-strand breaks (DSBs)?
Base Editors use a Cas9 nickase, which only cuts one strand of the DNA (a nick), rather than a standard Cas9, which causes a DSB (cuts both strands). The nick guides repair, while the fused deaminase enzyme performs the base conversion chemically.
3. Why is Base Editing better than traditional homologous recombination (HDR) in V. natriegens?
HDR is generally inefficient in bacteria, particularly for subtle changes. Base editing is HDR-independent, meaning it achieves much higher editing efficiency (often >50%) and drastically reduces unwanted insertion/deletion (indel) byproducts common in DSB repair.
4. Can Base Editing be used to perform gene knockouts?
Yes, indirectly. By converting a C to T, we can introduce a premature stop codon (e.g., CAA to TAA, CAG to TAG, or TGG to TGA). This results in a functional gene knockout (a truncation) with high precision.
5. How do you ensure high editing specificity in a fast-growing host like V. natriegens?
We use transient, inducible expression of the Base Editor to ensure the enzyme is present only long enough to perform the edit, minimizing the opportunity for off-target activity on the rapidly replicating V. natriegens genome.
6. Is the editing possible on both V. natriegens chromosomes (Chr I and Chr II)?
Yes. Our gRNA design pipeline screens against the entire V. natriegens genome, allowing us to successfully design gRNAs to target specific loci on either Chromosome I or Chromosome II for editing.
7. What is the Base Editor's "editing window"?
The editing window is the specific range of bases (typically 4 to 8 bases upstream of the PAM sequence) where the deaminase enzyme can chemically perform the base conversion. Our design ensures the target base falls within this active window.
8. What is the typical turnaround time for a Base Editing project?
Due to the high efficiency and simplified screening process of Base Editing, projects typically take less time than traditional editing. Turnaround time depends on complexity (e.g., single target vs. multiplexed edits) but is significantly accelerated by the high-growth rate of the V. natriegens host itself.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.